Investment Advisory Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,295
Closed -$219K 196
2025
Q4
$219K Sell
2,295
-5
-0.2% -$490 0.06% 183
2025
Q3
$225K Hold
2,300
0.06% 177
2025
Q2
$247K Buy
2,300
+2
+0.1% +$202 0.07% 150
2025
Q1
$232K Buy
2,298
+5
+0.2% +$503 0.08% 149
2024
Q4
$205K Buy
+2,293
New +$202K 0.07% 161
2024
Q3
Sell
-2,650
Closed -$204K 170
2024
Q2
$204K Buy
+2,650
New +$194K 0.08% 161

Other funds holding BSX

Investment Advisory Group's BSX Position: Q1 2026 in Review

Investment Advisory Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,295 shares — an estimated $219K sold.

Investment Advisory Group first reported a position in BSX in Q2 2024 and held it in 6 quarters. The position peaked at $247K in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Investment Advisory Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Investment Advisory Group sold 2,295 Boston Scientific shares in Q1 2026, an estimated $219K.
  • Investment Advisory Group first reported a position in Boston Scientific in Q2 2024 and held it in 6 quarters.
  • Investment Advisory Group's Boston Scientific position peaked at $247K in Q2 2025.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Investment Advisory Group's 13F filing for Q1 2026, filed 22 Apr 2026.